NYACK 2018 Update in Allergy and Asthma

June 2, 2018

This course is designed to provide the practicing clinician, both generalists and allergy and pulmonary specialists, with updates on the diagnosis and management of asthma, food and drug allergies and atopic dermatitis. The didactic lecture component, geared for both generalists and specialists, will focus on recent advances in the evaluation and treatment of asthma and allergies.

Our goal is to provide a unique, interactive course that elucidates the scientific advances which support current clinical practice guidelines for asthma and allergy management.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and NYACK 2018 Update in Allergy and Asthma.  The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of  4.0 AMA PRA Category 1 CreditsPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

Funding
This activity has no commercial support.

Target Audience

Practicing allergists, pulmonary specialists and allied health professionals

Learning Objectives

At the conclusion of this meeting, learners should be able to:

-Accurately diagnose food allergies so that appropriate diets and measures can be taken.

-Accurately diagnose and label drug allergies for better patient outcomes and antibiotic stewardship

-Better identify asthma patients who would benefit from new biologic treatments for better patient outcomes

-Improve diagnosis and management of urticarial and atopic dermatitis patients and refer to appropriate specialist for new therapies

Additional information
Disclosure: 

Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Luz Fonacier, MD:

  Regeneron – honorarium, advisory board member, contracted research

  Shire – contracted research to NYU Winthrop Hospital

  Pfizer – research grant to NYU Winthrop Hospital

John Oppenheimer, MD

  Astra Zeneca – consulting fee

  GlaxoSmithKline – consulting fee

  DBV Technologies – consulting fee

  Sanofi – consulting fee

The following have no relevant financial relationships to disclose:

Lourdes de Asis, MD, MPH

Manish Ramesh, MD

Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Course opens: 
06/02/2018
Course expires: 
06/02/2020
Event starts: 
06/02/2018 - 8:00am
Event ends: 
06/02/2018 - 1:00pm
Cost:
$0.00
Rating: 
0
Crestview Conference Center
440 W. Nyack Road
West Nyack, NY
United States
+1 (877) 315-0239

Available Credit

  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance

Accreditation Period

Course opens: 
06/02/2018
Course expires: 
06/02/2020

Price

Cost:
$0.00
Please login or create an account to take this course.